{"id":"https://openalex.org/W2088757697","doi":"https://doi.org/10.1097/cco.0b013e328011a25f","title":"Ba/F3 cells and their use in kinase drug discovery","display_name":"Ba/F3 cells and their use in kinase drug discovery","alternate_titles":[],"publication_year":2006,"publication_date":"2006-11-24","ids":{"openalex":"https://openalex.org/W2088757697","doi":"https://doi.org/10.1097/cco.0b013e328011a25f","mag":"2088757697","pmid":"https://pubmed.ncbi.nlm.nih.gov/17133113"},"language":"en","primary_location":{"id":"doi:10.1097/cco.0b013e328011a25f","doi":"https://doi.org/10.1097/cco.0b013e328011a25f","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cco.0b013e328011a25f","pdf_url":null,"source":{"id":"https://openalex.org/S179395531","display_name":"Current Opinion in Oncology","issn_l":"1040-8746","issn":["1040-8746","1080-8140","1531-703X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2088757697"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084059598","display_name":"Markus Warmuth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I127128434","display_name":"Genomics Institute of the Novartis Research Foundation","ror":"https://ror.org/017136v53","country_code":"US","type":"facility","lineage":["https://openalex.org/I127128434","https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Markus Warmuth","raw_affiliation_strings":["Kinase Platform and Department of Lead Discovery, Genomics Institute of the Novartis Research Foundation, San Diego, California 92121, USA. mwarmuth@gnf.org","Kinase Platform and Department of Lead Discovery, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA","to Markus Warmuth, MD, Kinase Platform, Genomics Institute of the Novartis Research Foundation (GNF), 10675 John Jay Hopkins Dr, San Diego, CA 92121, USA E-mail: [email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kinase Platform and Department of Lead Discovery, Genomics Institute of the Novartis Research Foundation, San Diego, California 92121, USA. mwarmuth@gnf.org","institution_ids":["https://openalex.org/I127128434"]},{"raw_affiliation_string":"Kinase Platform and Department of Lead Discovery, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA","institution_ids":["https://openalex.org/I127128434"]},{"raw_affiliation_string":"to Markus Warmuth, MD, Kinase Platform, Genomics Institute of the Novartis Research Foundation (GNF), 10675 John Jay Hopkins Dr, San Diego, CA 92121, USA E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I127128434"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sungjoon Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I127128434","display_name":"Genomics Institute of the Novartis Research Foundation","ror":"https://ror.org/017136v53","country_code":"US","type":"facility","lineage":["https://openalex.org/I127128434","https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sungjoon Kim","raw_affiliation_strings":["Kinase Platform and Department of Lead Discovery, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kinase Platform and Department of Lead Discovery, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA","institution_ids":["https://openalex.org/I127128434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109938939","display_name":"Xiang-ju Gu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I127128434","display_name":"Genomics Institute of the Novartis Research Foundation","ror":"https://ror.org/017136v53","country_code":"US","type":"facility","lineage":["https://openalex.org/I127128434","https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xiang-ju Gu","raw_affiliation_strings":["Kinase Platform and Department of Lead Discovery, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kinase Platform and Department of Lead Discovery, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA","institution_ids":["https://openalex.org/I127128434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103237673","display_name":"Gang Xia","orcid":"https://orcid.org/0000-0002-5177-1054","observed_orcids":["https://orcid.org/0000-0002-5177-1054"]},"institutions":[{"id":"https://openalex.org/I127128434","display_name":"Genomics Institute of the Novartis Research Foundation","ror":"https://ror.org/017136v53","country_code":"US","type":"facility","lineage":["https://openalex.org/I127128434","https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gang Xia","raw_affiliation_strings":["Kinase Platform and Department of Lead Discovery, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kinase Platform and Department of Lead Discovery, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA","institution_ids":["https://openalex.org/I127128434"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049021582","display_name":"Francisco Adri\u00e1n Cabestr\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I127128434","display_name":"Genomics Institute of the Novartis Research Foundation","ror":"https://ror.org/017136v53","country_code":"US","type":"facility","lineage":["https://openalex.org/I127128434","https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Francisco Adri\u00e1n","raw_affiliation_strings":["Kinase Platform and Department of Lead Discovery, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kinase Platform and Department of Lead Discovery, Genomics Institute of the Novartis Research Foundation, San Diego, California, USA","institution_ids":["https://openalex.org/I127128434"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5084059598"],"corresponding_institution_ids":["https://openalex.org/I127128434"],"apc_list":null,"apc_paid":null,"fwci":0.3876,"has_fulltext":false,"cited_by_count":269,"citation_normalized_percentile":{"value":0.40680272,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"19","issue":"1","first_page":"55","last_page":"60"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.49390000104904175,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.49390000104904175,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.28299999237060547,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.06920000165700912,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ba-f3-cells","display_name":"Ba/F3 cells","score":0.9990000128746033},{"id":"https://openalex.org/keywords/protein-kinases","display_name":"protein kinases","score":0.9309999942779541},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.8140000104904175},{"id":"https://openalex.org/keywords/kinase-drug-discovery","display_name":"kinase drug discovery","score":0.7570000290870667},{"id":"https://openalex.org/keywords/oncogenes","display_name":"oncogenes","score":0.609000027179718},{"id":"https://openalex.org/keywords/small-molecule-kinase-inhibitors","display_name":"small-molecule kinase inhibitors","score":0.777999997138977},{"id":"https://openalex.org/keywords/high-throughput-screening","display_name":"high-throughput screening","score":0.7799999713897705},{"id":"https://openalex.org/keywords/compound-profiling","display_name":"compound profiling","score":0.6129999756813049},{"id":"https://openalex.org/keywords/drug-resistance-prediction","display_name":"drug resistance prediction","score":0.6439999938011169},{"id":"https://openalex.org/keywords/point-mutations","display_name":"point mutations","score":0.7310000061988831},{"id":"https://openalex.org/keywords/downstream-signaling","display_name":"downstream signaling","score":0.7229999899864197},{"id":"https://openalex.org/keywords/interleukin-3-dependence","display_name":"interleukin-3 dependence","score":0.6759999990463257}],"concepts":[{"id":"https://openalex.org/C54174078","wikidata":"https://www.wikidata.org/wiki/Q3197188","display_name":"Kinome","level":3,"score":0.9775257706642151},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.7163311839103699},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.7005822062492371},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.5047601461410522},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.48920202255249023},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38974249362945557},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3689943850040436},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32512032985687256},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2954972982406616},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2910991311073303},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22483685612678528}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002471","descriptor_name":"Cell Transformation, Neoplastic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004815","descriptor_name":"Epidermal Growth Factor","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/cco.0b013e328011a25f","doi":"https://doi.org/10.1097/cco.0b013e328011a25f","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cco.0b013e328011a25f","pdf_url":null,"source":{"id":"https://openalex.org/S179395531","display_name":"Current Opinion in Oncology","issn_l":"1040-8746","issn":["1040-8746","1080-8140","1531-703X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Oncology","raw_type":"journal-article"},{"id":"pmid:17133113","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17133113","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":60,"referenced_works":["https://openalex.org/W256532953","https://openalex.org/W1639582946","https://openalex.org/W1841041873","https://openalex.org/W1937853139","https://openalex.org/W1963579412","https://openalex.org/W1965295262","https://openalex.org/W1966376566","https://openalex.org/W1971248653","https://openalex.org/W1977926787","https://openalex.org/W1980568348","https://openalex.org/W1982659189","https://openalex.org/W1982720580","https://openalex.org/W1984375602","https://openalex.org/W1985785718","https://openalex.org/W1987264710","https://openalex.org/W1988750150","https://openalex.org/W1999614615","https://openalex.org/W2003984225","https://openalex.org/W2011474502","https://openalex.org/W2012952884","https://openalex.org/W2033753214","https://openalex.org/W2039787813","https://openalex.org/W2041440798","https://openalex.org/W2042905219","https://openalex.org/W2043696829","https://openalex.org/W2045156702","https://openalex.org/W2049140059","https://openalex.org/W2049145190","https://openalex.org/W2057147161","https://openalex.org/W2057360098","https://openalex.org/W2063512315","https://openalex.org/W2065251641","https://openalex.org/W2073051869","https://openalex.org/W2081284522","https://openalex.org/W2086626683","https://openalex.org/W2088123597","https://openalex.org/W2090004346","https://openalex.org/W2092606584","https://openalex.org/W2096575996","https://openalex.org/W2104485296","https://openalex.org/W2111973486","https://openalex.org/W2113230030","https://openalex.org/W2113344287","https://openalex.org/W2117563665","https://openalex.org/W2119674879","https://openalex.org/W2121695889","https://openalex.org/W2124196948","https://openalex.org/W2126920848","https://openalex.org/W2128153005","https://openalex.org/W2131351052","https://openalex.org/W2131476854","https://openalex.org/W2133952555","https://openalex.org/W2144664431","https://openalex.org/W2146239050","https://openalex.org/W2146758625","https://openalex.org/W2159082261","https://openalex.org/W2159863363","https://openalex.org/W2161821474","https://openalex.org/W2164452916","https://openalex.org/W2625712844"],"related_works":["https://openalex.org/W4282977685","https://openalex.org/W4389227901","https://openalex.org/W4362541349","https://openalex.org/W3003630315","https://openalex.org/W4415766272","https://openalex.org/W4393086257","https://openalex.org/W2233144399","https://openalex.org/W4388731516","https://openalex.org/W2122518703","https://openalex.org/W2025729335"],"abstract_inverted_index":{"PURPOSE":[0],"OF":[1],"REVIEW:":[2],"Due":[3],"to":[4,7,95,110,126,152,163,180],"their":[5,101],"ability":[6,90,151],"function":[8],"as":[9,73],"dominant":[10],"oncogenes,":[11,87],"protein":[12],"kinases":[13],"have":[14,106],"become":[15],"favored":[16],"targets":[17],"in":[18,34,40,123,146,170,188],"the":[19,35,38,48,80,89,154,175],"quest":[20],"for":[21,50,77,114],"'molecularly-targeted'":[22],"cancer":[23],"chemotherapeutics.":[24],"The":[25,150],"discovery":[26],"of":[27,31,85,91,157,177],"a":[28,63,74],"large":[29],"number":[30],"cancer-associated":[32],"mutations":[33,133],"kinome,":[36],"and":[37,53,82,88,162,167],"progress":[39],"developing":[41],"specific":[42],"small-molecule":[43,92,127],"kinase":[44,55,86,93,97,128,147,160],"inhibitors":[45,94,129],"has":[46],"increased":[47],"need":[49],"accurate,":[51],"reproducible,":[52],"efficient":[54],"activity-dependent":[56],"cellular":[57],"assay":[58,112],"systems.":[59],"RECENT":[60],"FINDINGS:":[61],"Ba/F3,":[62],"murine":[64],"interleukin-3":[65],"dependent":[66],"pro-B":[67],"cell":[68],"line":[69],"is":[70],"increasingly":[71,143],"popular":[72,144],"model":[75],"system":[76],"assessing":[78],"both":[79],"potency":[81],"downstream":[83],"signaling":[84],"block":[96],"activity.":[98],"Facilitated":[99],"by":[100,131],"growth":[102],"properties,":[103],"Ba/F3":[104,139,178],"cells":[105,140,179],"recently":[107],"been":[108],"adapted":[109],"high-throughput":[111,171],"formats":[113],"compound":[115,168],"profiling.":[116],"Further,":[117],"several":[118],"published":[119],"approaches":[120],"show":[121],"promise":[122],"predicting":[124],"resistance":[125,183],"elicited":[130],"point":[132],"interfering":[134],"with":[135,174],"inhibitor":[136],"binding.":[137],"SUMMARY:":[138],"are":[141],"an":[142],"tool":[145],"drug":[148,165],"discovery.":[149],"test":[153],"transforming":[155],"capacity":[156],"newly":[158],"identified":[159],"mutations,":[161],"profile":[164],"candidates":[166],"libraries":[169],"fashion,":[172],"combined":[173],"use":[176],"predict":[181],"clinical":[182],"will":[184],"greatly":[185],"facilitate":[186],"developments":[187],"this":[189],"field.":[190]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2088757697","counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":18},{"year":2024,"cited_by_count":28},{"year":2023,"cited_by_count":23},{"year":2022,"cited_by_count":26},{"year":2021,"cited_by_count":21},{"year":2020,"cited_by_count":17},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
